bpc-157 adverse effects humans BPC-157: Experimental Peptide Creates Risk for Athletes BPC-157 Side Effects: Flushing, Allergies

Innovative anti-cd38 and anti-bcma targeted therapies in multiple myeloma: Mechanisms of action and resistance

The transition between TRT providers is one of the most mismanaged moment

If endometriosis involves systemic inflammation, then systemic anti-inflammatory approaches make biological sense

5-Amino-1MQ (5-Amino-1-methylquinolinium) is a novel small molecule peptide classified as an NNMT inhibitor meaning it blocks the activity of the enzyme nicotinamide N-methyltransferase (NNMT), which plays a key role in cellular energy metabolism , fat storage , and aging

Our trained professionals will assess your suitability for the treatment during your consultation